RDC-0313 (ALKS 33)

RDC-0313 · Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RDC-0313 (ALKS 33), covering 2011-08-23 to 2011-08-23. Get the full timeline:

Most recent: Clinical Trial Update: ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder [Phase 2]